BiotechTube
Home/Precigen/James S. Turley
JS

James S. Turley

Lead Independent Director

Precigen

Therapeutic Areas

Immuno-oncologyAutoimmune DisordersInfectious Diseases

Precigen Pipeline

DrugIndicationPhase
PAPZIMEOS (zopapogene imadenovec-drba)Recurrent Respiratory Papillomatosis (RRP)Approved
AdenoVerse Immunotherapy / Cytokine TherapyImmuno-oncology, Autoimmune Disorders, Infectious DiseasesNot Specified
UltraCAR-THematologic Cancers, Solid TumorsNot Specified

Leadership Team at Precigen

HS
Helen Sabzevari, PhD
President and CEO
RR
Rutul R. Shah
Chief Operating Officer
PT
Phil Tennant
Chief Commercial Officer
HT
Harry Thomasian Jr.
Chief Financial Officer
DE
Douglas E. Brough, PhD
SVP, Head of Research
BT
Bryan T. Butman, PhD
SVP, Head of CMC
SM
Steven M. Harasym
Investor Relations
AR
Amy R. Lankford, PhD
SVP, Head of Clinical Operations and Regulatory Affairs
DL
Donald Lehr, JD
Chief Legal Officer
RR
Rob Russell
VP, Head of Human Resources
View full Precigen profile